About Us / FEBICO is the world leading microalgae manufacturer of Organic Spirulina, Organic Chlorella, Spirulina natural, Chlorella natural, and using its advanced fermentation facilities to produce high quality nattokinase and spore-forming probiotics. FEBICO has more than 4-decades of professional experiences in microalgae production and proudly won the world renowned reputation for its best and cleanest quality Spirulina, Chlorella. FEBICO is committed to provide highest quality microalgae superfoods and health supplements to our global customers along with our best services.

1. Largest microalgae supplier in Asia

FEBICO has a 140,000 m2 manufacturing site with over 60 microalgae culture ponds in beautiful Ping-Tung County at southern Taiwan. With our proprietary technology, our yearly production capacity can reach more than 1,000 tons microalgae. Our clients are located mostly in Japan, Europe, and US. FEBICO's mission is to provide quality microalgae products to serve public's nutritional, cosmetic, and biomedical needs.

2. Microalgae cultivated in an unpolluted, native environment

FEBICO's microalgae is cultivated in pure mountain spring water from Mt. Da-Wu. It is located in an environmentally unpolluted area submerged with constant sunlight. Yearly average temperature is around 25℃. It is the most beautiful and ideal site for Spirulina and Chlorella cultivation.

3. Multiple certifications attributed from professional research team.

• Organic Chlorella and Spirulina certified by USDA National Organic Program (NOP), Naturland (an IFOAM accredited association), Halal Certificate
• Our production facility is certified by HACCP, ISO 22000, and GMP.
• Research ability is accredited by multiple patents in Taiwan (chlorella cracked cell wall) and US patent.

4. High-valued biotechnology company

Through years of research experiences and investment, FEBICO has extracted a natural substance Apogen to effectively prevent infections and replication of enterovirus 71 and influenza A, B. Studies has published in the Journal of Medical Virology 70:119-125 (2003) and approved by US patent (US6346408) in 2001. A complete series of Flogen phycobiliproteins, for In Vitro diagnostic use.